Construction and Evaluation of Drug‐Metabolizing Cell Line for Bioartificial Liver Support System

T. Omasa,Kazumi Kim,Shinya Hiramatsu,Y. Katakura,M. Kishimoto,S. Enosawa,H. Ohtake
DOI: https://doi.org/10.1021/bp049757a
2008-09-05
Abstract:Focusing on drug metabolism in liver, we constructed and evaluated a drug‐metabolizing bioartificial liver (BAL) support system. In a previous study, we constructed ammonia‐metabolizing CHO and hepatoma‐derived HepG2 cell lines by recombination of the glutamine synthetase (GS) gene. For further mimicking of liver metabolism, the human hepatoma‐derived cell line HepG2 was transformed by the pBudCE‐GS‐CYP3A4 vector, which contains GS and drug‐metabolizing CYP 3A4 genes. The constructed GS‐3A4‐HepG2 cell line showed 3A4 activity higher than that of human primary hepatocytes. The drug‐metabolizing activity of BAL (BAL clearance) was evaluated using this cell line. The estimated clearance was higher than that of the human hepatocyte system.
What problem does this paper attempt to address?